Project cooperationUpdated on 9 January 2026
Meaningful and Faithful Computational, Multi-omics Based Simulations of Cancer Evolution for Validation and Prediction
Professor at Università degli Studi di Milano-Bicocca
Milan, Italy
About
The number of analysis methods and tools developed to hash interpretations out of "data" (e.g., bulk and single-cell sequencing data, or imaging data for spatial transcriptomics) being published each year is enormous. Each of these tools needs "validation", which is usually done by running extensive simulations of the scenarios the researchers have in front.
However, there is not a clear notion yet of a "digital twin" against which to run these validation tests (*). This is particularly true in the field of (solid) tumor evolution.
We are therefore interested in pursuing the goal of producing a multi-omics and AI integrated tumor digital-twin capable of recapitulating spatial growth of a solid tumor in a tissue while tracking its genotype at the single-cell level. For this we are leveraging our previous work on colon cancer development and the distribution of a prototype single-cell lineage-aware simulator called J-Space.
(*) Towards credible digital twins for basic and preclinical research, Colleen E. Clancy & Bennett A. Landman, Nature Reviews, 2026-01-08.
Similar opportunities
Project cooperation
Digital-twins for personalized medicine
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
Giuseppe Sciume
Associate Professor at University of Bordeaux
Bordeaux, France
Project cooperation
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Fernando Torres Andón
Miguel Servet Researcher at INIBIC
A Coruña, Spain
Project cooperation
Cancer, Fibrosis and Coagulation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Alessandra Metelli
Researcher at IRCCS Regina Elena National Cancer Institute
Rome, Italy